Page last updated: 2024-11-03

ro 31-8220 and Carcinoma, Hepatocellular

ro 31-8220 has been researched along with Carcinoma, Hepatocellular in 2 studies

Ro 31-8220: a protein kinase C inhibitor

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Westermann, P1
Knoblich, M1
Maier, O1
Lindschau, C1
Haller, H1
Marino, M1
Distefano, E1
Caporali, S1
Ceracchi, G1
Pallottini, V1
Trentalance, A1

Other Studies

2 other studies available for ro 31-8220 and Carcinoma, Hepatocellular

ArticleYear
Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles.
    The Biochemical journal, 1996, Dec-01, Volume: 320 ( Pt 2)

    Topics: Carcinoma, Hepatocellular; Cell Fractionation; Cell Line; Cell-Free System; Cytoplasmic Granules; Eg

1996
beta-estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells.
    Journal of cellular physiology, 2001, Volume: 188, Issue:2

    Topics: Androstadienes; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; DNA Repli

2001